Resources search

Measuring private sector corruption

ROSE-ACKERMAN, Susan
September 2007

Expand view

This paper looks at the role of donors in curtailing corrupt behaviour in the private sector, such as commercial bribery - particularly in developing and emerging countries where the sector is growing in importance

Competition and corruption : what can the donor commuity do?

SORIDE, Tina
September 2007

Expand view

This Brief discusses how corruption might threaten the benefits of competition in a market. Corruption can result in too much market power for some firms and thus increase prices and negatively influence the supply of goods and services in the private sector. While improved competition is important to cut prices, to improve the business climate, and to reduce the impacts of corruption, better regulation of markets is also an achievable objective in many countries, and an area where aid agencies can exert influence

Money in politics : transparency in action

FONTANA, Alessandra
September 2007

Expand view

Fostering disclosure of political finance information regarding public as well as private funds is key to address money's undue influence over democratic processes. However, aid donors are still reluctant to engage in what they see as a country's ‘internal politics'. This case-based brief, based on the experience of the Crinis Project, discusses the issue of transparency in political finance as an attempt to curb money's disruptive role in politics

Anti-corruption in the health sector : preventing drug diversion through supply chain management

VIAN, Taryn
October 2006

Expand view

This case-based brief describes how the President’s Emergency Plan for AIDS Relief (the US PEPFAR initiative) and the related Supply Chain Management System (SCMS) Project are working to increase transparency and provide a secure, high-quality supply of HIV/AIDS drugs to developing countries in Africa and Asia. Drug supply is an essential component of health care systems, accounting for 10-30 percent of health care costs. Drugs can be expensive, and willingness to pay for drugs is high, creating the danger that employees will divert drugs for re-packaging and sale in the grey market, or for personal use

Corruption in the health sector

U4 ANTI-CORRUPTION RESOURCE CENTRE
2006

Expand view

This resource presents some essential resources for anyone promoting anti-corruption in the health sector, or otherwise wanting to learn about the challenges of corruption in the health sector. It is a document-version of the web-based U4 Theme pages on corruption in the health sector

Corruption in the health sector : literature review

U4 ANTI-CORRUPTION RESOURCE CENTRE

Expand view

This is a literature review of resources relating to various aspects of the health sector. It is divided into sections, including: general information; corruption in the health sector; documents from international anti-corruption conferences; pay reform, salaries and informal payments; staff recruitment, posting, ethical training, ethical codes; budgets and financing; and procurement

E-bulletin